Natixis’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,706
| Closed | -$51K | – | 1111 |
|
|
2024
Q4 | $51K | Sell |
2,706
-515
| -16% | -$9.7K | ﹤0.01% | 867 |
|
|
2024
Q3 | $72.4K | Sell |
3,221
-408
| -11% | -$9.17K | ﹤0.01% | 753 |
|
|
2024
Q2 | $75.7K | Sell |
3,629
-1,154
| -24% | -$24.1K | ﹤0.01% | 744 |
|
|
2024
Q1 | $70.3K | Sell |
4,783
-689
| -13% | -$10.1K | ﹤0.01% | 786 |
|
|
2023
Q4 | $56.5K | Sell |
5,472
-288
| -5% | -$2.97K | ﹤0.01% | 790 |
|
|
2023
Q3 | $45.3K | Sell |
5,760
-19
| -0.3% | -$149 | ﹤0.01% | 816 |
|
|
2023
Q2 | $57.7K | Sell |
5,779
-1,301
| -18% | -$13K | ﹤0.01% | 821 |
|
|
2023
Q1 | $62.9K | Sell |
7,080
-441
| -6% | -$3.92K | ﹤0.01% | 801 |
|
|
2022
Q4 | $82.6K | Buy |
+7,521
| New | +$82.6K | ﹤0.01% | 829 |
|
|
2022
Q1 | – | Sell |
-7,970
| Closed | -$231K | – | 1275 |
|
|
2021
Q4 | $231K | Sell |
7,970
-526
| -6% | -$15.2K | ﹤0.01% | 1154 |
|
|
2021
Q3 | $255K | Buy |
+8,496
| New | +$255K | ﹤0.01% | 1120 |
|